CARPENTER TECHNOLOGY CORP

CRS

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 403,296Value: $127.0M

**Signal Note: Driehaus Capital initiates $127M position in Carpenter Technology** This signal warrants scrutiny given the mismatch: Driehaus is a biotech-focused growth fund, yet Carpenter Technology is a specialty materials company (advanced alloys, titanium) with minimal pharma exposure. The position likely reflects either (1) a sector rotation trade into industrials benefiting from aerospace/defense spending, or (2) a data error in the filing. Without confirmed biotech rationale, this appears outside Driehaus's stated mandate and merits clarification on investment thesis before drawing firm conclusions.

More CRS Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: